Subscribe
Sign In
Tag: CBT > Medical Marijuana and Cannabidiol Research Expansion Act
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
Cannabis Rescheduling
Biden’s Failed Actions on Cannabis Issues ‘Borders on Political Malpractice,’ Lawmaker Says
Rep. Earl Blumenauer asked Health Secretary Xavier Becerra to relay his concerns on cannabis reform to the president during a committee hearing.
March 22, 2024
Top Stories
Lawmakers 'Deeply Concerned' About Medical Cannabis Act's Implementation
Congressmen Earl Blumenauer and Andy Harris sent a letter requesting answers from the DEA and HHS on barriers to cannabis research and the government agencies’ missed report deadline that is required by the Medical Marijuana and Cannabidiol Research Expansion Act.
March 12, 2024
Page 1 of 1